Similarly, under the TNM-M scoring system, tumours from T4 patients (n = 7) tended to have higher GAS6 expression compared to T1 (n = 32), T2 (n = 21), and T3 (n = 107) patients (patients with smaller tumours) (P = 0.07163) (Figure 2(b)). This evidence concerns the gene GAS6 and neoplasm.